Jiangsu Pacific minok bio Pharmaceutical Co., Ltd
  • PMBP had a successful Pre-IND meeting for Meplazumab for acute and preventive treatment of malaria with the US FDA on August 15, 2019.
  • August 15,2019

  • PREVIOUS:Meplazumab was approved for pha...
  • NEXT:US FDA designated as a Fast Tra...
    Stay up to date on Pacific Meinuoke
    © Pacific Meinuoke         Legal Notice       苏ICP备10218680号-1